(FXC) iShares China Large Cap - Ratings and Ratios
China, Large, Cap, Equities
Description: FXC iShares China Large Cap
The iShares China Large Cap UCITS ETF, ticker symbol FXC, is a Switzerland-domiciled investment vehicle that tracks the Morningstar China TME NR USD Index, providing investors with exposure to Chinas largest and most liquid equities. As a China Equity ETF, it offers a diversified portfolio of top Chinese companies, allowing investors to tap into the countrys growth potential.
From a technical analysis perspective, the ETFs price action indicates a relatively stable trend, with the short-term Simple Moving Average (SMA20) at 102.64 and the current price at 102.22, suggesting a minor pullback. The medium-term SMA50 at 98.95 and long-term SMA200 at 92.14 indicate a positive trend, with the ETF trading above its long-term average. The Average True Range (ATR) of 1.36, equivalent to 1.33%, implies moderate volatility. Given the current technical setup, a potential forecast could be a continuation of the uptrend, with a target price above 109.43, the 52-week high.
Fundamentally, the ETFs Assets Under Management (AUM) stand at 968.58M USD, indicating a sizable and liquid investment vehicle. Considering the growth prospects of the Chinese economy and the ETFs diversified portfolio of large-cap stocks, it is likely that the AUM will continue to grow, attracting more investors seeking exposure to Chinas growth story.
Combining technical and fundamental insights, a forecast for FXC could be a potential price appreciation, driven by the ongoing growth of the Chinese economy and the ETFs diversified portfolio. If the current uptrend continues, the ETF could reach new highs, potentially surpassing the 52-week high of 109.43. However, investors should be cautious of potential volatility, as indicated by the ATR, and monitor the ETFs price action and fundamental developments closely.
Additional Sources for FXC ETF
FXC ETF Overview
Market Cap in USD | 969m |
Category | China Equity |
TER | 0.74% |
IPO / Inception | 2004-10-21 |
FXC ETF Ratings
Growth Rating | -3.09 |
Fundamental | - |
Dividend Rating | 26.8 |
Rel. Strength | 25.9 |
Analysts | - |
Fair Price Momentum | 107.68 USD |
Fair Price DCF | - |
FXC Dividends
Dividend Yield 12m | 2.95% |
Yield on Cost 5y | 2.50% |
Annual Growth 5y | -8.24% |
Payout Consistency | 93.4% |
Payout Ratio | % |
FXC Growth Ratios
Growth Correlation 3m | 91.1% |
Growth Correlation 12m | 85.6% |
Growth Correlation 5y | -57% |
CAGR 5y | -1.39% |
CAGR/Max DD 5y | -0.02 |
Sharpe Ratio 12m | 0.64 |
Alpha | 33.45 |
Beta | 0.643 |
Volatility | 24.84% |
Current Volume | 4.9k |
Average Volume 20d | 1.5k |
Stop Loss | 101.7 (-3.5%) |
As of July 09, 2025, the stock is trading at USD 105.36 with a total of 4,861 shares traded.
Over the past week, the price has changed by -0.28%, over one month by +0.70%, over three months by +20.46% and over the past year by +44.21%.
Neither. Based on ValueRay´s Analyses, iShares China Large Cap is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -3.09 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FXC is around 107.68 USD . This means that FXC is currently overvalued and has a potential downside of 2.2%.
iShares China Large Cap has no consensus analysts rating.
According to our own proprietary Forecast Model, FXC iShares China Large Cap will be worth about 122.6 in July 2026. The stock is currently trading at 105.36. This means that the stock has a potential upside of +16.32%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 122.6 | 16.3% |